Comparison of 
Generated at Tuesday, April 1, 2025 1:39:06 PM

### v2 Vaccines Administered (code = CVX) (parenteral, un

|      |     |
| ---: | --- |
| Package | hl7.fhir.r2.core@1.0.2 |
| VS Name | v2 Vaccines Administered (code = CVX) (parenteral, un |
| Canonical URL | `http://hl7.org/fhir/ValueSet/v2-0292` |
| Version | 2.8.2 |
| Description | FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered (code = CVX) (parenteral, un) |
| Status | `Active` |
| Has Escape Valve Code | `False` |
| Database Key | `595` |
| Database Concept Count | `124` |
| Database Active Concept Count | `124` |
### Bindings

| Source | Element | Binding | Strength | Element Short |
| ------ | ------- | ------- | -------- | ------------- |

### Referenced Systems

* `http://hl7.org/fhir/v2/0292`
### Empty Projection

This Value Set resulted in no projection (no mappings to other packages).

### Codes

| System | Code | Display |
| ------ | ---- | ------- |
| `http://hl7.org/fhir/v2/0292` | `01` | DTP |
| `http://hl7.org/fhir/v2/0292` | `02` | OPV |
| `http://hl7.org/fhir/v2/0292` | `03` | MMR |
| `http://hl7.org/fhir/v2/0292` | `04` | M/R |
| `http://hl7.org/fhir/v2/0292` | `05` | measles |
| `http://hl7.org/fhir/v2/0292` | `06` | rubella |
| `http://hl7.org/fhir/v2/0292` | `07` | mumps |
| `http://hl7.org/fhir/v2/0292` | `08` | Hep B, adolescent or pediatric |
| `http://hl7.org/fhir/v2/0292` | `09` | Td (adult) |
| `http://hl7.org/fhir/v2/0292` | `10` | IPV |
| `http://hl7.org/fhir/v2/0292` | `100` | pneumococcal conjugate |
| `http://hl7.org/fhir/v2/0292` | `101` | typhoid, ViCPs |
| `http://hl7.org/fhir/v2/0292` | `102` | DTP-Hib-Hep B |
| `http://hl7.org/fhir/v2/0292` | `103` | meningococcal C conjugate |
| `http://hl7.org/fhir/v2/0292` | `104` | Hep A-Hep B |
| `http://hl7.org/fhir/v2/0292` | `105` | vaccinia (smallpox) diluted |
| `http://hl7.org/fhir/v2/0292` | `106` | DTaP, 5 pertussis antigens6 |
| `http://hl7.org/fhir/v2/0292` | `107` | DTaP, NOS |
| `http://hl7.org/fhir/v2/0292` | `108` | meningococcal, NOS |
| `http://hl7.org/fhir/v2/0292` | `109` | pneumococcal, NOS |
| `http://hl7.org/fhir/v2/0292` | `11` | pertussis |
| `http://hl7.org/fhir/v2/0292` | `110` | DTaP-Hep B-IPV |
| `http://hl7.org/fhir/v2/0292` | `111` | influenza, live, intranasal |
| `http://hl7.org/fhir/v2/0292` | `112` | tetanus toxoid, NOS |
| `http://hl7.org/fhir/v2/0292` | `113` | Td (adult) |
| `http://hl7.org/fhir/v2/0292` | `114` | meningococcal A,C,Y,W-135 diphtheria conjugate |
| `http://hl7.org/fhir/v2/0292` | `115` | Tdap |
| `http://hl7.org/fhir/v2/0292` | `116` | rotavirus, pentavalent |
| `http://hl7.org/fhir/v2/0292` | `117` | VZIG (IND) |
| `http://hl7.org/fhir/v2/0292` | `118` | HPV, bivalent |
| `http://hl7.org/fhir/v2/0292` | `119` | rotavirus, monovalent |
| `http://hl7.org/fhir/v2/0292` | `12` | diphtheria antitoxin |
| `http://hl7.org/fhir/v2/0292` | `120` | DTaP-Hib-IPV |
| `http://hl7.org/fhir/v2/0292` | `121` | zoster |
| `http://hl7.org/fhir/v2/0292` | `122` | rotavirus, NOS1 |
| `http://hl7.org/fhir/v2/0292` | `13` | TIG |
| `http://hl7.org/fhir/v2/0292` | `14` | IG, NOS |
| `http://hl7.org/fhir/v2/0292` | `15` | influenza, split (incl. purified surface antigen) |
| `http://hl7.org/fhir/v2/0292` | `16` | influenza, whole |
| `http://hl7.org/fhir/v2/0292` | `17` | Hib, NOS |
| `http://hl7.org/fhir/v2/0292` | `18` | rabies, intramuscular injection |
| `http://hl7.org/fhir/v2/0292` | `19` | BCG |
| `http://hl7.org/fhir/v2/0292` | `20` | DTaP |
| `http://hl7.org/fhir/v2/0292` | `21` | varicella |
| `http://hl7.org/fhir/v2/0292` | `22` | DTP-Hib |
| `http://hl7.org/fhir/v2/0292` | `23` | plague |
| `http://hl7.org/fhir/v2/0292` | `24` | anthrax |
| `http://hl7.org/fhir/v2/0292` | `25` | typhoid, oral |
| `http://hl7.org/fhir/v2/0292` | `26` | cholera |
| `http://hl7.org/fhir/v2/0292` | `27` | botulinum antitoxin |
| `http://hl7.org/fhir/v2/0292` | `28` | DT (pediatric) |
| `http://hl7.org/fhir/v2/0292` | `29` | CMVIG |
| `http://hl7.org/fhir/v2/0292` | `30` | HBIG |
| `http://hl7.org/fhir/v2/0292` | `31` | Hep A, pediatric, NOS |
| `http://hl7.org/fhir/v2/0292` | `32` | meningococcal |
| `http://hl7.org/fhir/v2/0292` | `33` | pneumococcal |
| `http://hl7.org/fhir/v2/0292` | `34` | RIG |
| `http://hl7.org/fhir/v2/0292` | `35` | tetanus toxoid |
| `http://hl7.org/fhir/v2/0292` | `36` | VZIG |
| `http://hl7.org/fhir/v2/0292` | `37` | yellow fever |
| `http://hl7.org/fhir/v2/0292` | `38` | rubella/mumps |
| `http://hl7.org/fhir/v2/0292` | `39` | Japanese encephalitis |
| `http://hl7.org/fhir/v2/0292` | `40` | rabies, intradermal injection |
| `http://hl7.org/fhir/v2/0292` | `41` | typhoid, parenteral |
| `http://hl7.org/fhir/v2/0292` | `42` | Hep B, adolescent/high risk infant2 |
| `http://hl7.org/fhir/v2/0292` | `43` | Hep B, adult4 |
| `http://hl7.org/fhir/v2/0292` | `44` | Hep B, dialysis |
| `http://hl7.org/fhir/v2/0292` | `45` | Hep B, NOS |
| `http://hl7.org/fhir/v2/0292` | `46` | Hib (PRP-D) |
| `http://hl7.org/fhir/v2/0292` | `47` | Hib (HbOC) |
| `http://hl7.org/fhir/v2/0292` | `48` | Hib (PRP-T) |
| `http://hl7.org/fhir/v2/0292` | `49` | Hib (PRP-OMP) |
| `http://hl7.org/fhir/v2/0292` | `50` | DTaP-Hib |
| `http://hl7.org/fhir/v2/0292` | `51` | Hib-Hep B |
| `http://hl7.org/fhir/v2/0292` | `52` | Hep A, adult |
| `http://hl7.org/fhir/v2/0292` | `53` | typhoid, parenteral, AKD (U.S. military) |
| `http://hl7.org/fhir/v2/0292` | `54` | adenovirus, type 4 |
| `http://hl7.org/fhir/v2/0292` | `55` | adenovirus, type 7 |
| `http://hl7.org/fhir/v2/0292` | `56` | dengue fever |
| `http://hl7.org/fhir/v2/0292` | `57` | hantavirus |
| `http://hl7.org/fhir/v2/0292` | `58` | Hep C |
| `http://hl7.org/fhir/v2/0292` | `59` | Hep E |
| `http://hl7.org/fhir/v2/0292` | `60` | herpes simplex 2 |
| `http://hl7.org/fhir/v2/0292` | `61` | HIV |
| `http://hl7.org/fhir/v2/0292` | `62` | HPV, quadrivalent |
| `http://hl7.org/fhir/v2/0292` | `63` | Junin virus |
| `http://hl7.org/fhir/v2/0292` | `64` | leishmaniasis |
| `http://hl7.org/fhir/v2/0292` | `65` | leprosy |
| `http://hl7.org/fhir/v2/0292` | `66` | Lyme disease |
| `http://hl7.org/fhir/v2/0292` | `67` | malaria |
| `http://hl7.org/fhir/v2/0292` | `68` | melanoma |
| `http://hl7.org/fhir/v2/0292` | `69` | parainfluenza-3 |
| `http://hl7.org/fhir/v2/0292` | `70` | Q fever |
| `http://hl7.org/fhir/v2/0292` | `71` | RSV-IGIV |
| `http://hl7.org/fhir/v2/0292` | `72` | rheumatic fever |
| `http://hl7.org/fhir/v2/0292` | `73` | Rift Valley fever |
| `http://hl7.org/fhir/v2/0292` | `74` | rotavirus, tetravalent |
| `http://hl7.org/fhir/v2/0292` | `75` | vaccinia (smallpox) |
| `http://hl7.org/fhir/v2/0292` | `76` | Staphylococcus bacterio lysate |
| `http://hl7.org/fhir/v2/0292` | `77` | tick-borne encephalitis |
| `http://hl7.org/fhir/v2/0292` | `78` | tularemia vaccine |
| `http://hl7.org/fhir/v2/0292` | `79` | vaccinia immune globulin |
| `http://hl7.org/fhir/v2/0292` | `80` | VEE, live |
| `http://hl7.org/fhir/v2/0292` | `81` | VEE, inactivated |
| `http://hl7.org/fhir/v2/0292` | `82` | adenovirus, NOS1 |
| `http://hl7.org/fhir/v2/0292` | `83` | Hep A, ped/adol, 2 dose |
| `http://hl7.org/fhir/v2/0292` | `84` | Hep A, ped/adol, 3 dose |
| `http://hl7.org/fhir/v2/0292` | `85` | Hep A, NOS |
| `http://hl7.org/fhir/v2/0292` | `86` | IG |
| `http://hl7.org/fhir/v2/0292` | `87` | IGIV |
| `http://hl7.org/fhir/v2/0292` | `88` | influenza, NOS |
| `http://hl7.org/fhir/v2/0292` | `89` | polio, NOS |
| `http://hl7.org/fhir/v2/0292` | `90` | rabies, NOS |
| `http://hl7.org/fhir/v2/0292` | `91` | typhoid, NOS |
| `http://hl7.org/fhir/v2/0292` | `92` | VEE, NOS |
| `http://hl7.org/fhir/v2/0292` | `93` | RSV-MAb |
| `http://hl7.org/fhir/v2/0292` | `94` | MMRV |
| `http://hl7.org/fhir/v2/0292` | `95` | TST-OT tine test |
| `http://hl7.org/fhir/v2/0292` | `96` | TST-PPD intradermal |
| `http://hl7.org/fhir/v2/0292` | `97` | TST-PPD tine test |
| `http://hl7.org/fhir/v2/0292` | `98` | TST, NOS |
| `http://hl7.org/fhir/v2/0292` | `99` | RESERVED - do not use3 |
| `http://hl7.org/fhir/v2/0292` | `998` | no vaccine administered5 |
| `http://hl7.org/fhir/v2/0292` | `999` | unknown |
